NFKB inhibitor alpha
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
La NFKBIA gene provides instructions for making one piece (the alpha subunit) of the IKK protein complex, which is a group of related proteins that regulates the activity of nuclear factor-kappa-B. Nuclear factor-kappa-B is a protein complex that binds to DNA and controls the activity of other genes. When it is turned off (inactive), nuclear factor-kappa-B is attached (bound) to the IKK complex. In response to certain signals, the IKK complex turns on (activates) nuclear factor-kappa-B and releases it.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
La NFKBIA gene provides instructions for making one piece (the alpha subunit) of the IKK protein complex, which is a group of related proteins that regulates the activity of nuclear factor-kappa-B. Nuclear factor-kappa-B is a protein complex that binds to DNA and controls the activity of other genes. When it is turned off (inactive), nuclear factor-kappa-B is attached (bound) to the IKK complex. In response to certain signals, the IKK complex turns on (activates) nuclear factor-kappa-B and releases it.
The NFKBIA protein helps keep nuclear factor-kappa-B bound in the IKK complex. When the NFKBIA protein receives a signal that nuclear factor-kappa-B is to be released, it breaks down so the factor can be turned on (activated) and released from the complex. Once the active factor is released, it moves into the nucleus and binds to DNA. Nuclear factor-kappa-B regulates the activity of multiple genes, including genes that control the body's immune responses and inflammatory reactions. Nuclear factor-kappa-B also appears to play a role in the signaling pathway that is critical for the formation of ectodermal tissues including the skin, hair, teeth, and sweat glands. In addition, it protects the cell from certain signals that would otherwise cause it to self-destruct (undergo apoptosis).
Conditions referring to this gene or chromosome
Other names
I-kappa-B-alpha
IkappaBalpha
ikB-alpha
IKBA
IKBA_HUMAN
MAD-3
major histocompatibility complex enhancer-binding protein MAD3
NF-kappa-B inhibitor alpha
NFKBI
nuclear factor of kappa light chain gene enhancer in B-cells
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
Related patient information and medicines

Patient information leaflet
Spondylarthrite ankylosante
Ankylosing spondylitis is an auto-immune disease. It is not known exactly why ankylosing spondylitis occurs but there is a ge... In ankylosing spondylitis, a chemical called cytokine tumour necrosis factor alpha (TNF-alpha) is involved in causing inflammation. In the UK the National Institute for Health and Care Excellence (NICE) recommends that.

Patient information leaflet
Arthrite psoriasique
The National Institute for Health and Care Excellence (NICE) guidelines advise that etanercept, infliximab, adalimumab or golimumab should be offered as an option for treating adults with psoriatic arthritis when: The person has arthritis with three or more tender joints and three or more swollen joints; and When at least two other DMARDs, given.

Patient information leaflet
Hypertension artérielle
High blood pressure (hypertension) happens when the force on the walls of blood vessels (caused by the blood within them) is more than normal. ...vessels (caused by the blood within them) is more than normalHealthcare professionals sometimes call high blood pressure 'hypertension'..

Patient information leaflet
Régurgitation mitrale
La mitral valve est a heart valve that lies between the left atrium and left ventricle. ...eart - mitral valve incompetence i88_l.jpg What is mitral regurgitationAlthough medicines cannot correct mitral regurgitation, some medicines may be prescribed to help ease symptoms, or to help prevent complications by managing your blood pressure - for.

Patient information leaflet
Médicament pour l'hypertension
For detailed information about your own medication you should read the leaflet that comes inside the medicine packet. What are the types of blood pressure medicines. There are six main classes de les médicaments that are used to lower blood pressure: Angiotensin-converting enzyme (ACE) inhibitors. Alpha blockers Alpha blockers are usually added in to.

Patient information leaflet
maladie de Parkinson
Diagnosing Parkinson's disease is based on symptoms. If your GP suspects that you may have Parkinson's disease, you will be referred to a neurology specialist. You will likely have some tests in hospital to rule out other causes of your symptoms, such as ... Surgery may be an option for severe cases. The National Institute for Health and Care.
Lectures complémentaires et références
- NFKB inhibitor alpha; MedlinePlus, National Library of Medicine.
- Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, Dupuis-Girod S, Bodemer C, Livadiotti S, Novelli F, Rossi P, Fischer A, Israel A, Munnich A, Le Deist F, Casanova JL. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest. 2003 Oct;112(7):1108-15. doi: 10.1172/JCI18714.
- Kawai T, Nishikomori R, Heike T. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol Int. 2012 Jun;61(2):207-17. doi: 10.2332/allergolint.12-RAI-0446.
- McDonald DR, Mooster JL, Reddy M, Bawle E, Secord E, Geha RS. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J Allergy Clin Immunol. 2007 Oct;120(4):900-7. doi: 10.1016/j.jaci.2007.08.035.
- Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol. 2004 Feb;16(1):34-41. doi: 10.1016/j.coi.2003.11.013.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

